Pharma's New Worldview: Transforming R&D through Emerging Markets

Pharma's New Worldview: Transforming R&D through Emerging Markets

Cover
Large pharma companies consider R&D such a defining capability, they've been hesitant to move these activities outside the firm-much less offshore. This paper addresses new market forces that are compelling them to consider a range of alternatives, including outsourcing and offshore opportunities.

Authors

Heather Fraser Pharmacist, Global Leader, IBM Heather Fraser is a pharmacist with over 20 years of industry experience and has held positions within R&D, consultancy and community pharmacy. She is currently the global leader for the Life Sciences / Pharma team at the IBM Institute for Business Value. Heather has published a variety of articles on pharmaceutical industry issues in publications such as Pharmaceutical Technology, GCP Journal, PharmaFocus Asia, Biopartnering Today and Financier Worldwide Biotechnology Review. She has also been invited to speak at a number of industry conferences, including the DIA Annual World Conference.
Isabelle Pontille Global Learning and Knowledge Manager, IBM Isabelle Pontille has over 18 years experience working across various industries in both Western and Eastern Europe, having been based in Poland for 8 years. As a management consultant, her experience in the pharma sector includes extensive work around timeto- market and commercial strategy, in both developed and emerging markets. She has been invited to speak at a number of industry conferences, including the opening session of a conference in Warsaw about Polish Health reform. Isabelle now works as a Global Learning and Knowledge Manager for IBM.
Vendor:
IBM Line of Business
Posted:
17 Jun 2008
Published:
01 Sep 2006
Format:
PDF
Length:
20 Page(s)
Type:
White Paper
Language:
English

Download Your White Paper Now!